Autoimmunity

SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection
Enrique Morales, Maria Galindo

Annals of the Rheumatic Diseases Sep 2022, 81 (9) 1337-1338; DOI: 10.1136/annrheumdis-2022-222512
Two cases with new onset of ANCA-positive eosinophilic granulomatosis with polyangiitis under treatment with dupilumab: coincidence or causality?
Marcus von Deimling, Thomas C Koehler, Bjoern Christian Frye, Elisabeth Maerker-Hermann, Nils Venhoff

Annals of the Rheumatic Diseases Apr 2023, 82 (4) 580-582; DOI: 10.1136/ard-2022-223596
Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development
Bruno Raposo, Marcelo Afonso, Lena Israelsson, Heidi Wähämaa, Ragnhild Stålesen, Fredrik Wermeling, Aase Haj Hensvold, Caroline Grönwall, Bence Rethi, Lars Klareskog, Vivianne Malmström

Annals of the Rheumatic Diseases May 2023, 82 (5) 724-726; DOI: 10.1136/ard-2022-223417
Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern
Jean-Baptiste Vulsteke, Yves Piette, Carolien Bonroy, Patrick Verschueren, Daniel Blockmans, Steven Vanderschueren, Kristl G Claeys, Petra De Haes, Jan Leo Lenaerts, Wim A Wuyts, Takashi Matsushita, Vanessa Smith, Ellen De Langhe, Xavier Bossuyt

Annals of the Rheumatic Diseases May 2022, 81 (5) 742-744; DOI: 10.1136/annrheumdis-2021-220004
Extracellular aaRSs drive autoimmune and inflammatory responses in rheumatoid arthritis via the release of cytokines and PAD4
Akihiro Kimura, Takeshi Takagi, Thiprampai Thamamongood, Satoshi Sakamoto, Takumi Ito, Iwao Seki, Masahiro Okamoto, Hiroyuki Aono, Satoshi Serada, Tetsuji Naka, Hiroaki Imataka, Kensuke Miyake, Takuya Ueda, Miki Miyanokoshi, Keisuke Wakasugi, Noriko Iwamoto, Norio Ohmagari, Takahiro Iguchi, Takeshi Nitta, Hiroshi Takayanagi, Hiroyuki Yamashita, Hiroshi Kaneko, Haruka Tsuchiya, Keishi Fujio, Hiroshi Handa, Harumi Suzuki

Annals of the Rheumatic Diseases Sep 2023, 82 (9) 1153-1161; DOI: 10.1136/ard-2023-224055
Correspondence on “Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis”
Jean Roudier

Annals of the Rheumatic Diseases Sep 2023, 82 (9) e203; DOI: 10.1136/annrheumdis-2022-222750
Response to: Correspondence on “HLA-DR ‘naturally’ presented peptides: you will find what you have pulsed with” by Roudier
Diego Catalan, Dolores Jaraquemada, Juan C Aguillón

Annals of the Rheumatic Diseases Sep 2023, 82 (9) e204; DOI: 10.1136/annrheumdis-2022-222758
Fever, rhinosinusitis and glomerulonephritis with systemic inflammation and antimyeloperoxidase antibody
Motohiro Yokota, Nobuya Abe, Miyuki Bohgaki, Hideki Kasahara

Annals of the Rheumatic Diseases Nov 2022, 81 (11) 1623-1624; DOI: 10.1136/ard-2022-222937
Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: ‘Correspondence on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases’ by Giollo et al
Kimme L Hyrich, Milena Gianfrancesco, Pedro M Machado, Jinoos Yazdany, Philip C Robinson

Annals of the Rheumatic Diseases Nov 2022, 81 (11) e223; DOI: 10.1136/annrheumdis-2020-218910
Correspondence on “European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance”
Xavier Bossuyt, Walter Fierz, Pier Luigi Meroni

Annals of the Rheumatic Diseases Aug 2023, 82 (8) e193; DOI: 10.1136/annrheumdis-2021-221288

Main menu

Autoimmunity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Autoimmunity

Pages